Approval · Notice of Compliance 31070 · 2023
PAXLOVID: Notice of Compliance 31070
Issued June 27, 2023
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 31070
- Date
- June 27, 2023
- Company
- Pfizer Canada UlcKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Updates to the Product Monograph (PM) with Post-Market Adverse Reactions and Drug-Drug Interactions.
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PAXLOVID | Not yet assigned | — |
Medicinal ingredients
- RITONAVIR 100 MG per TAB
- NIRMATRELVIR 150 MG per TAB